Navigation Links
University Health Industries Launches Natural Pet Health Care Division
Date:6/30/2008

University Health Industries Inc., (OTCBB:UVHI) a Florida corporation engaged in the development, marketing and sale of proprietary, patent-pending nutraceutical products, including its leading brands Arthroleve(TM) and Zenstral PMS(TM), announced today that it is launching a new pet health care division.

BOCA RATON, Fla. (Business Wire EON) June 30, 2008 -- The pet health care division is designed to expand University Health Industries' current market focus on human health into the pet health care market. The American Pet Product Manufactures Association (APPMA) estimates 2008 sales to be $10.3 billion for pet supplies and OTC medicines.

The lead product will be a pet formulated version of UHI's popular and successful Arthroleve™ product for joint health and arthritis, which will be designed with a dosage and delivery system specific to canines. Small animal veterinary analgesics has been one of the fastest growing segments of the pet health care market in the last ten years, since the launch of the non-steroidal anti-inflammatory drug (NSAID) Rimadyl® in 1996. Due to concerns over side effects associated with NSAIDS, many consumers choose to try nutraceutical products first. Currently, the canine joint health market is led primarily by glucosamine/chondroitin containing products including SynoviCare® and Cosequin®. UHI's adaptation of Artholeve™ for the canine market will allow us to offer consumers a unique patent-pending formulation with clinically-proven ingredients.

Dean Peloso, Chief Executive Officer of University Health Industries, was quoted as saying, "UHI's overall strategy has always included pet health care and we are excited about beginning the process of moving this forward. This new division complements the Company's current offerings in both its human health and environmental products."

University Health Industries' mission is to deliver the latest advances and discoveries in natural compounds packaged in our unique patented formulations including Arthroleve™ (www.arthroleve.com) as well as Zenstral PMS™ (www.zenstralpms.com) and delivered to satisfy the needs of consumers for the promotion of health for many common age-related health concerns. www.universityhealthindustries.com.

Safe Harbor Forward-Looking Statements:

Except for historical matters contained herein, the matters discussed in this press release are "forward-looking statements" within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Investors are cautioned that these forward-looking statements reflect numerous assumptions and involve risks and uncertainties that may affect University Health Industries, Inc. and its subsidiary businesses (collectively, the "Company") and prospects and cause actual results to differ materially from these forward-looking statements.

Keyword Tags: arthroleve, arthroleve.com, arthroleve testimonial, pet arthritis, pet health, pet health care, pets, university health industries


'/>"/>
Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved  

Related medicine news :

1. University of Iowa professor identifies new eating disorder
2. University of Wisconsin Hospitals and Clinics Complete System-Wide Conversion to Masimo SET Pulse Oximetry Technology
3. University of Texas Study Details Lengthy Payment Delays for Medicare Part D Prescription Drug Claims, Confirming Need for Legislative Fix
4. Tulane University to receive $14M for international HIV/AIDS program
5. University of Nevada School of Medicine Professor Confirms Accuracy Through Validation Study Using the CSI Health Station Model 6K
6. Boston University School of Medicine researcher recipient of Memory Ride Grant
7. Loma Linda University Medical Center Selects Beryl to Manage Call Center Interactions for Womens Services Programs and Departments
8. Medina General Hospital and University Hospitals Agree to Pursue Affiliation
9. J.D. Power and Associates Reports: Hackensack University Medical Center Recognized as First Hospital to Achieve Distinction for Providing an Outstanding Inpatient Experience in All Four Service Areas
10. The First Incisionless Transoral Fundoplication for Treatment of Gastroesophageal Reflux is Performed in the U.S. at Ohio State University and Oregon Health & Science University Medical Centers
11. George Mason University professor receives $2.6 million NIH grant to study Alzheimers disease
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
 University Health Industries Launches Natural Pet Health Care Division 
(Date:12/9/2016)... ... December 09, 2016 , ... Sober College, the game-changing ... grand opening of the Sober College Robert Pfeifer Memorial Learning Center at its ... and was attended by an overwhelming amount of alumni, family, colleagues and friends ...
(Date:12/9/2016)... ... December 09, 2016 , ... "I had a terrible time ... Winchester, Va. "I thought that if the nebulizer had a more child-friendly design, then ... them." , He developed the patent-pending NEBY to avoid the need to deliver medication ...
(Date:12/8/2016)... , ... December 08, 2016 , ... ... Franchising Company LLC, announced the first national #QuackGivesBack campaign which supported local ... “This was our first franchise-wide Quack Gives Back initiative, and we’re ...
(Date:12/8/2016)... ... ... With the increasing demand for dental implants, the National Association of Dental ... dentists and patients about the safety issues related to dental restorations. According to the ... is projected to reach $6.4 billion in 2018 with more than 30 million Americans ...
(Date:12/8/2016)... (PRWEB) , ... December 08, 2016 , ... ... technologies and development solutions for drugs, biologics and consumer health products, today announced ... was set up in 2006 as a non-profit organization to unite pharmaceutical and ...
Breaking Medicine News(10 mins):
(Date:12/9/2016)... 2016 Research and Markets has announced the addition ... report to their offering. ... The report also analyses the market by the following Technology Types: ... for the US, Canada , Japan ... Latin America , and Rest of World. ...
(Date:12/9/2016)... 9, 2016 aTyr Pharma, Inc. (Nasdaq: LIFE ... Physiocrine-based therapeutics to address severe, rare diseases, today announced that senior ... Prescriptions for Success Healthcare Conference at the InterContinental Barclay Hotel in ... 2016, at 4:20 p.m. ET. About aTyr Pharma ... aTyr Pharma ...
(Date:12/9/2016)... 2016  Forge Therapeutics, Inc. today announced a ... EVT, TecDAX, ISIN: DE0005664809) to advance its novel ... of bacterial infections including those caused by drug ... attractive antibacterial target for more than the past ... starting points has hampered its progress. Forge has ...
Breaking Medicine Technology: